Announcements Trials

Browse Landscape

Phase

Phase 1 4 Phase NA 1 Phase 2/3 1 Phase 2 1 Phase 1/2 1

Status

Unknown 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1

Interventions

Cyclophosphamide 739 Cisplatin 687 Gemcitabine 641 Bevacizumab 615 Carboplatin 604 Paclitaxel 600 Docetaxel 565 Radiotherapy 536 Fluorouracil 405 Oxaliplatin 387 Rituximab 369 Doxorubicin 360 Capecitabine 342 Filgrastim 333 Etoposide 328 Dexamethasone 312 Irinotecan 309 pembrolizumab 279 Leucovorin 274 Cetuximab 267 Cytarabine 242 Erlotinib Hydrochloride 231 Prednisone 227 Nivolumab 227 Trastuzumab 225 Bortezomib 221 Vincristine 220 Methotrexate 207 Pemetrexed 199 fludarabine phosphate 195

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Completed × Famotidine × Clear all

NCT03107182 2025-05-06

OPTIMA-II

University of Chicago

Phase 2 Completed

72 enrolled 14 charts

Squamous Cell Carcinoma of Head and Neck

Data powered by HemOnc (CC BY 4.0) Colophon ⚡